Foley & Lardner LLP announced today that Karen Mangasarian has joined the firm’s Chemical, Biotechnology & Pharmaceutical Practice as a partner in the New York office.
Mangasarian regularly counsels a diverse group of life sciences clients across a wide range of technology areas, including small molecule pharmaceuticals, pharmaceutical formulations, biologics, diagnostic and therapeutic methods in molecular and cellular biology, immunology, microbiology, biochemistry, genomics and computational biology.
“Karen’s extensive experience handling a variety of intellectual property matters for clients in the life sciences space, paired with her deep background in pharmacology and biochemistry, aligns well with our focus on helping clients maximize the value of, and protect, their technology,” said Kristel Schorr, Chair of the firm’s Chemical, Biotechnology & Pharmaceutical Practice.
Mangasarian works closely with her clients to provide patent counseling services, including obtaining international and domestic patent rights, creating competitive patent strategies, strategic planning, licensing and product life cycle management. She also has experience with post-grant procedures, such as interferences, re-examinations, oppositions and litigation.
“Karen brings an exceptional depth of patent counseling knowledge to Foley,” said Peter Wang, Managing Partner of the firm’s New York City office. “Her experience complements our office’s strong Patent Litigation and Trademark, Copyright & Advertising Litigation practices, as well as our robust national patent counseling work. We are delighted to have her join us as an integral part of our team.”
Prior to joining Foley, Mangasarian was a partner at Ropes & Gray LLP.